유방암 치료에 대한 한의 임상 가이드라인 개발을 위한 기초연구

키워드

참고문헌 (40)

1. "Breast Cancer"[URL]
2. 정경해, "진행성 유방암의 맞춤 항암요법의 최신 지견", 대한내과학회지, 77(1), pp.26~34 (2009), 대한내과학회
3. Chen Z, "Furenliangfangdaiquan", pp.71~ (1993), Jungdam
4. Chao Y, "Chaoshizhubingyuan-houlun", pp.296~ (1992), Daesung
5. Zhang J, "Jingyuequanshu", pp.697~ (1984), Shanghaikexuejishu
6. Li X, "Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in chinese", PLoS One, 8(4), pp.e60338~ (2013)
7. "Korea Breast Cancer Society Practice Recommendations of Breast Cancer" (2008)[URL]
8. "NCCN Guidelines-Breast Cancer"[URL]
9. Lim HS, "Guidelines for Diagnosis and Treatment of Malignant tumors in Chinese Medicine", pp.339~370 (2014), People’s Medical Publishing House
10. "Evidence Reports of Kampo Treatment 2010, 345 Randomized Controlled Trials" (2010)[URL]
11. Jones A, "Pilot Feasibility Study to Assess the Utility of PET Scanning in the Pre-Operative Evaluation of Internal Mammary Nodes in Breast Cancer Patients Presenting with Medial Hemisphere Tumors", Clin Positron Imaging, 2, pp.331~ (1991)
12. Isasi CR, "A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases", Breast Cancer Res Treat, 90, pp.105~112 (2005)
13. Cook GJ, "Detection of bone metastases in breast cancer by 18 FDG-PET: differing metabolic activity in osteoblastic and osteolytic lesions", J Clin Oncol, 16, pp.3375~3379 (1998)
14. Fisher B, "Prevention of invasive breast cancer in women with ductal carcinoma in situ : an update of the National Surgical Adjuvant Breast and Bowel Project experience", Semin Oncol, 28, pp.400~418 (2001)
15. Fisher B, "Tamoxifen in treatment of intraductal breast cancer : National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial", Lancet, 353, pp.1993~2000 (1999)
16. Cooke T, "HER2 as a prognostic and predictive marker for breast cancer", Ann Oncol, 12, pp.S23~S28 (2001)
17. American College of Radiology, "Practice guideline for the breast conservation therapy in the management of invasive breast carcinoma", J Am Coll Surg, 205, pp.362~376 (2007)
18. Hata T, "Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography", J Am Coll Surg, 198, pp.190~197 (2004)
19. Cheng JC, "Diagnostic thoracic computed tomography in radiotherapy for locoregional recurrent breast carcinoma", Int J Radiat Oncol Biol Phys, 41, pp.607~613 (1998)
20. Isasi CR, "A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases", Breast Cancer Res Treat, 90, pp.105~112 (2005)
21. Cook GJ, "Detection of bone metastases in breast cancer by 18FDG PET : differing metabolic activity in osteoblastic and osteolytic lesions", J Clin Oncol, 16, pp.3375~3379 (1998)
22. Edge SB, "AJCC (American Joint Committee on Cancer) Cancer Staging Manual", pp.143~ (2010), Springer
23. Early Breast Cancer Trialists’ Collaborative Group, "Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials", N Engl J Med, 333, pp.1444~1455 (1995)
24. Arriagada R, "Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group", J Clin Oncol, 14, pp.1558~1564 (1996)
25. Fisher B, "Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer", N Engl J Med, 347, pp.1233~1241 (2002)
26. Veronesi U, "Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer", N Engl J Med, 347, pp.1227~1232 (2002)
27. Early Breast Cancer Trialists’ Collaborative Group, "Polychemotherapy for early breast cancer: an overview of the randomized trials", Lancet, 352, pp.930~942 (1998)
28. Wood WC, "Dose and dose intensity of adjuvant chemotherapy for stageII, node-positive breast carcinoma", N Engl J Med, 330, pp.1253~1259 (1994)
29. Wolmark N, "Preoperative chemotherapy in patients with operable breast cancer : Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18", J Natl Cancer Inst Monogr, 30, pp.96~102 (2001)
30. Rastogi P, "Preoperative chemotherapy : Updates of National Surgical Adjuvant Breast and Bowel Project Protocol B-18 and B-27", J Clin Oncol, 26, pp.778~785 (2008)
31. Aman U. Buzdar, "Preoperative chemotherapy treatment of breast cancer-a review", Cancer, 110, pp.2394~2407 (2007)
32. LHRH-agonists in Early Breast Cancer Overview group, "Use of luteinising- hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials", Lancet, 369, pp.1711~1723 (2007)
33. Klijn JG, "Combined tamoxifen and luteinizing hormone-releasing hormone(LHRH)agonist versus LHRH agonist alone in premenopausal advanced breast cancer : a meta-analysis of four randomized trials", J Clin Oncol, 19, pp.343~353 (2001)
34. Hellman S, "Stopping metastases at their source", N Engl J Med, 337, pp.996~997 (2007)
35. Ragaz J, "Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer", N Engl J Med, 337, pp.956~962 (1997)
36. Ragaz J, "Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial", J Natl Cancer Inst, 97, pp.116~126 (2005)
37. Overgaard M, "Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial", N Engl J Med, 337, pp.949~955 (1997)
38. Overgaard M, "Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial", Lancet, 353, pp.1641~1648 (1999)
39. Danish Breast Cancer Cooperative Group, "Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82b and c randomized studies", J Clin Oncol, 24, pp.2268~2275 (2006)
40. Overgaard M, "Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials", Radiother Oncol, 82, pp.247~253 (2007)

관련 논문AI추천